1401 - 1450 of 8620 Results
Title
Year
-
OPENTitle: Correlation of Clinical Features With Argyrophilic Grains at AutopsyJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 23Issue #: 3Start Page: 229End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0b013e318199d833Best OA location URL: http://doi.org/10.1097/WAD.0b013e318199d833Citation Count: 41
- Comparative Analysis of the Alzheimer Questionnaire (AQ) With the CDR Sum of Boxes, MoCA, and MMSE2012OPENTitle: Comparative Analysis of the Alzheimer Questionnaire (AQ) With the CDR Sum of Boxes, MoCA, and MMSEJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page: 296End Page: 298Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0b013e3182769731Best OA location URL: http://doi.org/10.1097/WAD.0b013e3182769731Citation Count: 17
-
OPENTitle: Parkinson Disease With DementiaJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 23Issue #: 3Start Page: 295End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0b013e31819c5ef4Best OA location URL: http://doi.org/10.1097/WAD.0b013e31819c5ef4Citation Count: 201
- Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue2011OPENTitle: Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain TissueJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 26Issue #: 1Start Page: 8End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0b013e31821300bcBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3286131Citation Count: 128
-
OPENTitle: Onset of Mild Cognitive Impairment in Parkinson DiseaseJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 2Start Page: 127End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000088Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4592684Citation Count: 31
- Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers2016OPENTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2016.03.002Citation Count: 79
- Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia2016OPENTitle: Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal DementiaJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 1Start Page: 73End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000161Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5322244Citation Count: 67
-
OPENTitle: The Relationship Between Mobility Dysfunction Staging and Global Cognitive PerformanceJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 3Start Page: 230End Page: 236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000136Best OA location URL: http://doi.org/10.1097/WAD.0000000000000136Citation Count: 29
-
OPENTitle: Improving the clinical detection of Lewy body dementia with the Lewy body composite risk scoreJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 1Issue #: 3Start Page: 316End Page: 324Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2015.05.004Best OA location URL: https://doi.org/10.1016/j.dadm.2015.05.004Citation Count: 74
- Bayesian latent time joint mixed‐effects model of progression in the Alzheimer's Disease Neuroimaging Initiative2018OPENTitle: Bayesian latent time joint mixed‐effects model of progression in the Alzheimer's Disease Neuroimaging InitiativeJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 10Issue #: 1Start Page: 657End Page: 668Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2018.07.008Best OA location URL: https://escholarship.org/content/qt6cq9g6b3/qt6cq9g6b3.pdfCitation Count: 22
-
OPENTitle: The Quick Dementia Rating System (QDRS): A rapid dementia staging toolJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 1Issue #: 3Start Page: 249End Page: 259Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2015.03.003Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.dadm.2015.03.003Citation Count: 155
-
OPENTitle: Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 523End Page: 530Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182635645Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3413767Citation Count: 170
-
OPENTitle: “On” state freezing of gait in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 7Start Page: 454End Page: 457Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182477ec0Citation Count: 201
-
OPENTitle: Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian MennonitesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 9Start Page: 649End Page: 657Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182494d51Best OA location URL: https://n.neurology.org/content/neurology/78/9/649.full.pdfCitation Count: 90
-
OPENTitle: Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 1Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31823ed101Best OA location URL: https://n.neurology.org/content/neurology/78/1/55.full.pdfCitation Count: 39
-
OPENTitle: Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 3Start Page: 243End Page: 248Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31825fdeedBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3398434Citation Count: 110
-
OPENTitle: Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomalyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 11Start Page: 838End Page: 838Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318249f733Best OA location URL: https://n.neurology.org/content/neurology/78/11/838.full.pdfCitation Count: 7
-
OPENTitle: A comparison of nine scales to detect depression in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 13Start Page: 998End Page: 1006Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31824d587fCitation Count: 133
-
OPENTitle: Pearls & Oy-sters: Functional MRIJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318248e57aBest OA location URL: https://n.neurology.org/content/neurology/78/10/e68.full.pdfCitation Count: 1
- The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors2008OPENTitle: The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviorsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 32Issue #: 2Start Page: 229End Page: 242Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.06.018Best OA location URL: http://doi.org/10.1016/j.nbd.2008.06.018Citation Count: 62
- Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s disease2007OPENTitle: Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 29Issue #: 1Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2007.08.008Best OA location URL: http://doi.org/10.1016/j.nbd.2007.08.008Citation Count: 72
-
OPENTitle: Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 430End Page: 438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.02.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2605654Citation Count: 63
- A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease2009OPENTitle: A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 34Issue #: 3Start Page: 417End Page: 431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.02.009Best OA location URL: http://doi.org/10.1016/j.nbd.2009.02.009Citation Count: 189
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice2010OPENTitle: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 3Start Page: 503End Page: 517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2955774Citation Count: 266
- LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease2010OPENTitle: LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 1Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.04.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2926296Citation Count: 143
- VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease2009OPENTitle: VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 330End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.10.011Citation Count: 74
-
OPENTitle: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 41Issue #: 3Start Page: 706End Page: 716Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008Citation Count: 184
-
OPENTitle: Glial scars are permeable to the neurotoxic environment of chronic stroke infarctsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 63End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.007Best OA location URL: https://doi.org/10.1016/j.nbd.2018.01.007Citation Count: 109
-
OPENTitle: Alpha galactosidase A activity in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5811339Citation Count: 73
-
OPENTitle: Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 98Issue #:Start Page: 122End Page: 136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.11.004Best OA location URL: http://doi.org/10.1016/j.nbd.2016.11.004Citation Count: 13
-
OPENTitle: The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseasesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 109Issue #:Start Page: 226End Page: 248Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2016.12.013Best OA location URL: https://doi.org/10.1016/j.nbd.2016.12.013Citation Count: 235
-
OPENTitle: Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s DiseaseJournal Name: The AAPS JournalPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1208/s12248-009-9123-2Best OA location URL: https://link.springer.com/content/pdf/10.1208/s12248-009-9123-2.pdfCitation Count: 70
-
OPENTitle: Selective Small Molecule Inhibition of Poly(ADP-Ribose) Glycohydrolase (PARG)Journal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 7Issue #: 3Start Page: 563End Page: 570Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb200506tCitation Count: 50
- Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome Function2015OPENTitle: Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome FunctionJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 6Issue #: 4Start Page: 588End Page: 598Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cn500323qBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4838453Citation Count: 11
- Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease2009OPENTitle: Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative diseaseJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 515Issue #: 3Start Page: 269End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22040Best OA location URL: http://doi.org/10.1002/cne.22040Citation Count: 54
- Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non‐human primate after overexpression of GDNF2009OPENTitle: Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non‐human primate after overexpression of GDNFJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 515Issue #: 1Start Page: 31End Page: 40Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22028Best OA location URL: http://doi.org/10.1002/cne.22028Citation Count: 40
-
OPENTitle: Neurochemical phenotypes of myenteric neurons in the rhesus monkeyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 519Issue #: 17Start Page: 3387End Page: 3401Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22679Best OA location URL: http://doi.org/10.1002/cne.22679Citation Count: 25
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents2014OPENTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page: 2465End Page: 2480Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23583Best OA location URL: http://doi.org/10.1002/cne.23583Citation Count: 127
- Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases2016OPENTitle: Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylasesJournal Name: Journal of Enzyme Inhibition and Medicinal ChemistryPublisher: Informa UK LimitedVol: 31Issue #: sup2Start Page: 148End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/14756366.2016.1193734Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14756366.2016.1193734?needAccess=trueCitation Count: 12
- A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activity2011OPENTitle: A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activityJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 209Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20111126Best OA location URL: http://jem.rupress.org/content/jem/209/1/1.full.pdfCitation Count: 37
- Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning2010OPENTitle: Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoningJournal Name: Journal of General PhysiologyPublisher: Rockefeller University PressVol: 137Issue #: 1Start Page: 59End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1085/jgp.201010532Best OA location URL: https://rupress.org/jgp/article-pdf/137/1/59/1187438/jgp_201010532.pdfCitation Count: 163
-
OPENTitle: LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infectionJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 214Issue #: 10Start Page: 3051End Page: 3066Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20170014Best OA location URL: https://rupress.org/jem/article-pdf/214/10/3051/1166015/jem_20170014.pdfCitation Count: 146
- Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected Relatives2014OPENTitle: Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected RelativesJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 24Issue #: 2Start Page: 238End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-014-9756-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4331260Citation Count: 29
- Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers2017OPENTitle: Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease CarriersJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 3Start Page: 675End Page: 680Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0161-0Best OA location URL: https://europepmc.org/articles/pmc5878114?pdf=renderCitation Count: 20
-
OPENTitle: Citalopram for the Treatment of Agitation in Alzheimer DementiaJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 29Issue #: 2Start Page: 59End Page: 64Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0891988715601735Best OA location URL: http://doi.org/10.1177/0891988715601735Citation Count: 10
-
OPENTitle: Sertraline for the Treatment of Depression in Alzheimer Disease: Genetic InfluencesJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 24Issue #: 4Start Page: 222End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0891988711422527Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3535452Citation Count: 14
- An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients2017OPENTitle: An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease PatientsJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 7Start Page: 1741End Page: 1752Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12325-017-0571-2Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs12325-017-0571-2.pdfCitation Count: 27
- Characterization of fibromyalgia symptoms in patients 55–95 years old: a longitudinal study showing symptom persistence with suboptimal treatment2014OPENTitle: Characterization of fibromyalgia symptoms in patients 55–95 years old: a longitudinal study showing symptom persistence with suboptimal treatmentJournal Name: Aging Clinical and Experimental ResearchPublisher: Springer Science and Business Media LLCVol: 27Issue #: 1Start Page: 75End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s40520-014-0238-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4244273Citation Count: 36
- Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s Disease2016OPENTitle: Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 6Start Page: 745End Page: 745Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2016.0505Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147551Citation Count: 23
-
OPENTitle: Consensus classification of posterior cortical atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 8Start Page: 870End Page: 884Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2017.01.014Best OA location URL: http://www.alzheimersanddementia.com/article/S1552526017300407/pdfCitation Count: 554